Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClinOleic in Preterm Infants
NCT01683162Phase 4Unknown
- Start
- Jul 2012
- Primary completion
- Dec 2012
- Modality
- Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Clinoleic in preterm birth. Primary endpoint: Fatty acid levels (lipometabolism) at 14 days. Status: unknown.
02
Drugs
Clinoleic
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT01683162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683162.